Skip to search formSkip to main contentSkip to account menu

BMS-650032

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Asunaprevir (ASV; BMS-650032), a low nanomolar inhibitor of the hepatitis C virus (HCV) NS3 protease, is currently under… 
2015
2015
Abstract 1. Asunaprevir (ASV, BMS-650032), a highly selective and potent NS3 protease inhibitor, is currently under development… 
Review
2015
Review
2015
Asunaprevir, a second-generation NS3 protease inhibitor of hepatitis C virus (HCV), exhibits strong antiviral activity against… 
Highly Cited
2014
Highly Cited
2014
The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is… 
Highly Cited
2012
Highly Cited
2012
ABSTRACT Asunaprevir (ASV; BMS-650032) is a hepatitis C virus (HCV) NS3 protease inhibitor that has demonstrated efficacy in… 
2012
2012
ABSTRACT With the development of directly acting antivirals, hepatitis C virus (HCV) therapy entered a new era. However, rapid…